Cargando…

Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection

Inhibition of host-encoded targets, such as the cyclophilins, provides an opportunity to generate potent high barrier to resistance antivirals for the treatment of a broad range of viral diseases. However, many host-targeted agents are natural products, which can be difficult to optimize using synth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansson, Magnus Joakim, Moss, Steven James, Bobardt, Michael, Chatterji, Udayan, Coates, Nigel, Garcia-Rivera, Jose A., Elmér, Eskil, Kendrew, Steve, Leyssen, Pieter, Neyts, Johan, Nur-E-Alam, Mohammad, Warneck, Tony, Wilkinson, Barrie, Gallay, Philippe, Gregory, Matthew Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336584/ https://www.ncbi.nlm.nih.gov/pubmed/25619934 http://dx.doi.org/10.1016/j.chembiol.2014.10.023

Ejemplares similares

Both Cyclophilin Inhibitors and Direct-Acting Antivirals Prevent PKR Activation in HCV-Infected Cells
por: Bobardt, Michael, et al.
Publicado: (2014)

Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175
por: Gallay, Philippe A., et al.
Publicado: (2016)

Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a Reinfection
por: Chatterji, Udayan, et al.
Publicado: (2016)

The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice
por: Gallay, Philippe, et al.
Publicado: (2019)

Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production
por: Phillips, Sandra, et al.
Publicado: (2015)

Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma
por: Simón Serrano, Sonia, et al.
Publicado: (2021)

Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma
por: Simón Serrano, Sonia, et al.
Publicado: (2022)

The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action
por: Gallay, Philippe A., et al.
Publicado: (2015)

A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
por: Kuo, Joseph, et al.
Publicado: (2019)

DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A
por: Coelmont, Lotte, et al.
Publicado: (2010)

Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver Fibrosis
por: Simón Serrano, Sonia, et al.
Publicado: (2019)

The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice
por: Bobardt, Michael, et al.
Publicado: (2020)

The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity
por: Stauffer, Winston, et al.
Publicado: (2023)

The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity
por: Stauffer, Winston, et al.
Publicado: (2023)

Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis
por: Kuo, Joseph, et al.
Publicado: (2019)

HCV Core Residues Critical for Infectivity Are Also Involved in Core-NS5A Complex Formation
por: Gawlik, Katarzyna, et al.
Publicado: (2014)

Semisynthesis of Selenoauraptene
por: Fiorito, Serena, et al.
Publicado: (2021)

Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice
por: Bobardt, Michael, et al.
Publicado: (2020)

Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture
por: de Wilde, Adriaan H., et al.
Publicado: (2018)

The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate
por: Bobardt, Michael, et al.
Publicado: (2019)

The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance
por: Bobardt, Michael, et al.
Publicado: (2021)

Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor(®) EL
por: Ehinger, Karl Henrik Johannes, et al.
Publicado: (2012)

Erratum to: Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor(®) EL
por: Ehinger, Karl Henrik Johannes, et al.
Publicado: (2013)

Cyclosporine as Therapy for Traumatic Brain Injury
por: Hansson, Magnus J., et al.
Publicado: (2023)

Disease Outcome and Brain Metabolomics of Cyclophilin-D Knockout Mice in Sepsis
por: Kobayashi, Takayuki, et al.
Publicado: (2022)

The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication
por: Foster, R.T., et al.
Publicado: (2017)

Semisynthesis of Functional Glycosylphosphatidylinositol‐Anchored Proteins
por: Roller, Renée F., et al.
Publicado: (2020)

Biosynthesis of tetrahydropapaverine and semisynthesis of papaverine in yeast
por: Jamil, Osman K., et al.
Publicado: (2022)

Chemical Synthesis and Semisynthesis of Lipidated Proteins
por: Hanna, Cameron C., et al.
Publicado: (2022)

The semisynthesis of nucleolar human selenoprotein H
por: Dardashti, Rebecca Notis, et al.
Publicado: (2023)

HSV Neutralization by the Microbicidal Candidate C5A
por: de Witte, Lot, et al.
Publicado: (2011)

Curing a viral infection by targeting the host: The example of cyclophilin inhibitors
por: Lin, Kai, et al.
Publicado: (2013)

Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120
por: Binley, James M, et al.
Publicado: (2007)

Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120
por: Binley, James M, et al.
Publicado: (2006)

Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection
por: Hopkins, Sam, et al.
Publicado: (2012)

Aqueous semisynthesis of C-glycoside glycamines from agarose
por: Dallagnol, Juliana C Cunico, et al.
Publicado: (2017)

Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice
por: Gallay, Philippe A., et al.
Publicado: (2018)

Semisynthesis of Ribonuclease A using Intein-Mediated Protein Ligation
por: Arnold, Ulrich, et al.
Publicado: (2002)

Semisynthesis of Protein variants Using Intein-Mediated Protein Ligation
por: Arnold, Ulrich, et al.
Publicado: (2001)

Semisynthesis, Characterization and Evaluation of New Adenosine Derivatives as Antiproliferative Agents
por: Valdés Zurita, Francisco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q8gqejt7vp2t7lh0dl40r4k38g